These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12760217)

  • 1. [Immunotherapy against psoriasis].
    Gjersvik PJ
    Tidsskr Nor Laegeforen; 2003 Apr; 123(8):1049. PubMed ID: 12760217
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dermatology--new therapeutic possibilities. The Danish Society of Dermatology].
    Gniadecki R; Haedersdal M
    Ugeskr Laeger; 2006 Mar; 168(12):1213. PubMed ID: 16571304
    [No Abstract]   [Full Text] [Related]  

  • 3. A host of novel agents for treating psoriasis, psoriatic arthritis stir interest.
    Lamberg L
    JAMA; 2003 Jun; 289(21):2779-80, 2783. PubMed ID: 12783895
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunomodulation with fumaric acid. Systemic therapy in psoriasis].
    Sebók B; Schneider I
    Orv Hetil; 2000 Jan; 141(3):129-32. PubMed ID: 10693335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact immunotherapy-induced Renbök phenomenon in a patient with alopecia areata and psoriasis vulgaris.
    Ito T; Hashizume H; Takigawa M
    Eur J Dermatol; 2010; 20(1):126-7. PubMed ID: 19822483
    [No Abstract]   [Full Text] [Related]  

  • 6. New developments in the treatment of psoriasis.
    Rogers S
    Ir Med J; 1997; 90(5):178-9. PubMed ID: 9345825
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of severe psoriasis with anti-TNF-alpha-antibody and methotrexate].
    Dalaker M; Bonesrønning JH
    Tidsskr Nor Laegeforen; 2003 Apr; 123(8):1070-1. PubMed ID: 12760225
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in psoriasis treatment.
    Schön MP
    Lancet; 2005 Oct 15-21; 366(9494):1333-5. PubMed ID: 16226595
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunopathogenesis and immunotherapy of psoriasis.
    Griffiths TW; Griffiths CE; Voorhees JJ
    Dermatol Clin; 1995 Oct; 13(4):739-49. PubMed ID: 8785879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunology in clinical practice. VII. Psoriasis].
    Bos JD; de Rie MA
    Ned Tijdschr Geneeskd; 1997 Nov; 141(48):2334-8. PubMed ID: 9550823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent expression of CD26/DPPIV after treatment with infliximab in psoriasis despite clinical improvement.
    van Lingen RG; van Erp PE; Seyger MM; de Jong EM; de Boer-van Huizen RT; Driessen RJ; van de Kerkhof PC
    Acta Derm Venereol; 2009; 89(5):518-20. PubMed ID: 19734982
    [No Abstract]   [Full Text] [Related]  

  • 12. Consecutive use of different biological therapies in the treatment of psoriasis.
    Costanzo A; Papoutsaki M; Mazzotta A; Chimenti S
    Br J Dermatol; 2007 Aug; 157(2):394. PubMed ID: 17553044
    [No Abstract]   [Full Text] [Related]  

  • 13. Ustekinumab: when everything else fails?
    Vitiello M; Grant A; Kerdel FA
    Int J Dermatol; 2011 Apr; 50(4):478-82. PubMed ID: 21413963
    [No Abstract]   [Full Text] [Related]  

  • 14. [What are the objectives of moderate to severe psoriasis treatment?].
    Ortonne JP
    Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S281-4. PubMed ID: 18721665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guselkumab (Tremfya) for psoriasis.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):179-180. PubMed ID: 29125591
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate.
    Warren RB; Brown BC; Carmichael AJ; Griffiths CE
    Clin Exp Dermatol; 2009 Apr; 34(3):415-6. PubMed ID: 19120390
    [No Abstract]   [Full Text] [Related]  

  • 17. Department of Dermatology was blessed with a wonderful psoriasis specialist. Foreword.
    Feldman SR
    BioDrugs; 2013 Jan; 27 Suppl 1():1-2. PubMed ID: 23990276
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of moderate to severe psoriasis with systemic immunomodulatory therapies: a 5-year experience from two departments of dermatology of Northern France.
    Staumont-Sallé D; Florin V; Cottencin AC; Chaby G; Delaporte E
    J Eur Acad Dermatol Venereol; 2012 Aug; 26(8):1038-9. PubMed ID: 21812831
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab (Remicade) for acute, severe pustular and erythrodermic psoriasis.
    Lisby S; Gniadecki R
    Acta Derm Venereol; 2004; 84(3):247-8. PubMed ID: 15202853
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biological dermatologic agents. The Danish Society of Dermatology].
    Iversen L; Kragballe K;
    Ugeskr Laeger; 2007 Mar; 169(12):1100. PubMed ID: 17394811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.